Navigation Links
Sinovac Reports Unaudited Third Quarter 2009 Financial Results
Date:11/15/2009

d quarter of 2009 were mainly related to the completion of the H1N1 clinical trial and the continued development of the EV 71 vaccine, pneumococcal conjugated vaccine, and universal pandemic influenza vaccine.

Third quarter 2009 operating income was $12.4 million, compared to operating income of $2.3 million in the prior year. Net income for the third quarter of 2009 included $246,000 interest and financing expenses and $3.8 million in income tax expenses. Net income for the same period of 2008 included $190,000 of interest and financing expenses and $911,000 of income tax expenses. Net income attributable to shareholders for third quarter of 2009 was $5.2 million, or $0.12 per diluted share, up 606% compared to net income attributable to shareholders of $740,000, or $0.02 per diluted share, in the same period of 2008.

As of September 30, 2009, Sinovac's cash and cash equivalents totaled $46.6 million, compared to $32.9 million as of December 31, 2008. The increase in cash and cash equivalents primarily reflects an advance payment received for a vaccine-stockpiling program.

Financial Review for Nine Months Ended September 30, 2009

During the nine months ended September 30, 2009, sales were $47.8 million, up 40% from $34.1 million for the same period in 2008. Sinovac recorded strong revenues growth in the second and third quarters, which greatly improved the Company's performance for the year to date.

During the first nine months of 2009, Sinovac's unit dose sales were:

    Nine months ended September 30             2009              2008
    ------------------------------             ----              ----
                                           (000 doses)       (000 doses)
                                           -----------       -----------
    Healive                                   5,024             5,313

    Bilive                                      708               234

    A
'/>"/>
SOURCE Sinovac Biotech Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
2. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
3. Sinovac to Present at 2009 UBS Global Life Sciences Conference
4. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
5. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government
6. Sinovac Obtains Production License for H1N1 Vaccine
7. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
8. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
9. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
11. Sinovac Adjourns 2008 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... According to the International Atomic Energy Agency (IAEA) ... terrorists acquiring sufficient quantities of plutonium or highly ... explosive device. The IAEA also notes that most ... quantities, which can be challenging to detect with ... study appearing this week in the Journal ...
(Date:7/10/2014)... today in the journal PNAS (Proceedings of the ... of day and sleep deprivation have a significant effect ... looking at the best time of day to test ... for administering medicines effectively. , Researchers from the University ... investigated the links between sleep deprivation, body clock disruption ...
(Date:7/10/2014)... Wash. The lithium-ion batteries that power our laptops ... longer on a single charge with the help of ... porous material to replace the graphite traditionally used in ... than 10 times the energy storage capacity of graphite. ... battery electrode was published today in Nature Communications ...
(Date:7/10/2014)... recent study by researchers at the University of ... physical mechanisms governing the interplay of spin and ... limits of ultrafast spintronic devices for data storage ... charge as well as spin-angular momentum. In a ... there is no spin current," explained David Cahill, ...
Breaking Biology Technology:Sensitive detection method may help impede illicit nuclear trafficking 2Time of day crucial to accurately test for diseases, new research finds 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3University of Illinois study advances limits for ultrafast nano-devices 2
... ... stick that can be shipped from stock greatly minimizing lead times for Semiconductor tool ... (PRWEB) ... specializing in process controls for the delivery of critical fluids, introduces an innovation to ...
... , PLEASANTON, Calif., FRAMINGHAM, Mass. ... THOR ), a world leader in device-based mechanical circulatory support ... International, Inc. (Nasdaq: HTWR ; ASX: HIN), which ... the United States Federal Trade Commission ("FTC") has informed them ...
... , , BETHESDA, Md., July ... company developing novel, proprietary antibodies for the treatment of cancer, inflammation ... of its common stock in a public offering. Piper Jaffray & ... Capital Markets as co-manager in this offering. The offering is ...
Cached Biology Technology:Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 2Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 4Micromet Announces Public Offering of Common Stock 2Micromet Announces Public Offering of Common Stock 3Micromet Announces Public Offering of Common Stock 4
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
(Date:7/11/2014)... hippocampus, the marginal division of the striatum is ... the impact degree of substance P in the ... Yan Yu and his team, College of Biophotonics, ... staining, that substance P receptor, neurokinin 1 was ... division of normal rats. Unilateral or bilateral injection ...
(Date:7/11/2014)... , July 11, 2014 Research and ... "International Biometrics Technology Market - Industry Analysis Size Share ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... crimes has created a need for high level security ... for personnel authentication such as username and passwords, tokens ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... Prof. Makoto Tominaga and Dr. Takaaki Sokabe (National Institute ... in skin keratinocytes is important for formation and maintenance ... reported in the Journal of Biological Chemistry. ... namely "thermoTRPs". It is expressed in skin, acting as ...
... -- Astronauts are known to have a higher risk of ... go with weightlessness, confined crew quarters, being away from family ... while not getting enough sleep - are known to wreak ... by immunobiologist Ty Lebsack at the University of Arizona has ...
... same digital technology that enables young people to play video ... a simulated coral reef environment where they participate in science ... Field Museum scientists will link students from Chicago,s Austin neighborhood ... the Pacific Ocean, engage in the scientific process, and participate ...
Cached Biology News:Immune system compromised during spaceflight, study finds 2Immune system compromised during spaceflight, study finds 3Field Museum technology project wins prestigious award 2
Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
biotin-4-fluorescein...
... Consists of the LVF-HL, LVF-CUVADPT, FHS-LVF, and ... high-pass and low-pass Linear Variable Filters to ... an adjustable center wavelength and adjustable bandpass. ... (~90%) and blocking band (99.8%). These ...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Biology Products: